Daejeon, South Korea

Wan Sang Cho

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Wan Sang Cho in Anti-Inflammatory Research.

Introduction

Wan Sang Cho is an accomplished inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds with anti-inflammatory properties. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Wan Sang Cho holds a patent for a benzopyranyl tetracycle compound and a pharmaceutical composition that exhibits an excellent anti-inflammatory effect. This invention relates to a novel compound represented by specific formulas, which has shown remarkable efficacy in treating or preventing inflammatory diseases, especially sepsis. The compound works by inhibiting the translocation of HMGB1 from the nucleus to the cytosol, thereby providing a significant therapeutic benefit.

Career Highlights

Throughout his career, Wan Sang Cho has worked with notable organizations, including Spark Biopharma, Inc. and Seoul National University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Seung Bum Park and Ja Young Koo, who have played essential roles in his research endeavors. Their collaboration has further enhanced the impact of his work in the pharmaceutical industry.

Conclusion

Wan Sang Cho's innovative contributions to anti-inflammatory research highlight the importance of developing effective treatments for inflammatory diseases. His patented compound represents a significant advancement in the field, showcasing the potential for novel therapies to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…